InvestorsHub Logo

Bugzzie75

06/02/16 8:03 AM

#21605 RE: Bugzzie75 #21604

And now Mass produced*

Avoid

06/02/16 8:38 AM

#21606 RE: Bugzzie75 #21604

May 31, 2016 PositiveID Adds Benedikt von Braunmuhl to its Board of Advisors

Mr. von Braunmuhl has more than 20 years of experience with global healthcare companies, and will assist the Company’s efforts to commercialize Firefly Dx to detect Zika and other pathogens


DELRAY BEACH, Fla., May 31, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that it has added international healthcare and business development executive Benedikt von Braunmühl to its Board of Advisors.

Von Braunmühl is currently Chairman of the Board of Directors of PathoQuest, a next generation molecular diagnostics company with a unique approach in infectious diseases diagnostics. In addition, he acts as advisor of the healthcare practice group at Clairfield International, a mergers and acquisitions advisory firm for global mid-market transactions with 39 offices in 23 countries. He has held several high-profile healthcare consulting and advisory roles for companies across the globe supporting geographic expansion, business development, and mergers and acquisitions projects. Von Braunmühl previously was Senior Vice President - Global Commercial Operations of Qiagen NV, a leading European biotechnology company active in molecular diagnostics and life science markets.

“We are honored to add Benedikt to our Board of Advisors to raise awareness of our product offerings and our technical and scientific expertise among potential partners,” said William J. Caragol, Chairman and CEO of PositiveID. “We believe his strategic insights and broad industry relationships, which align closely with our business, will be valuable in helping us reach the next stage in our growth.”

Mr. von Braunmühl started his 25-year healthcare career at AstaMedica and has held various marketing and sales positions in the healthcare industry as well as in investment banking. He holds a Bachelor Degree in Business Administration from the Graduate School of Business Administration in Zurich, Switzerland.